Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:A001540) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,000 million worth of its shares pursuant to a contract with Small and Medium Business Bank. The purpose of the program is to stabilize stock price. The program will expire on January 7, 2022. As of January 7, 2021, the company had 1,322,067 shares in treasury within scope available for dividend and had 209,453 shares in treasury through other repurchases.